| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 02/18/1999 | WO1999007394A1 Use of herpes vectors for tumor therapy |
| 02/18/1999 | WO1999007386A1 Composition and method of treating cancer with tannic acid and tannin complexes |
| 02/18/1999 | WO1999007383A1 Composition and method for regulating cell proliferation and cell death |
| 02/18/1999 | WO1999007377A1 1-[4-(substituted alkoxy)benzyl]naphthalene compounds having estrogen inhibitory activity |
| 02/18/1999 | WO1999007324A2 Conjugates targeted to the interleukin-2 receptor |
| 02/18/1999 | WO1998029108A3 Compositions and methods for restoring a normal pattern of imprinting to cells |
| 02/18/1999 | WO1998014593A3 Human telomerase catalytic subunit |
| 02/18/1999 | CA2300977A1 Neutral sphingomyelinase |
| 02/18/1999 | CA2299630A1 Compositions that specifically bind to colorectal cancer cells and methods of using the same |
| 02/18/1999 | CA2299608A1 New epothilone derivatives, method for producing same and their pharmaceutical use |
| 02/18/1999 | CA2299368A1 Conjugates targeted to the interleukin-2 receptor |
| 02/18/1999 | CA2299322A1 Composition and method of treating cancer with tannic acid and tannin complexes |
| 02/18/1999 | CA2299309A1 Benzothiophenes |
| 02/18/1999 | CA2299269A1 Macrolides with antitumor activity |
| 02/18/1999 | CA2298932A1 Linear peptides derived from antibiotic peptides, preparation and use for vectoring active substances |
| 02/18/1999 | CA2298849A1 Lipoprotein-regulating medicaments |
| 02/18/1999 | CA2298651A1 1-¬4-(substituted alkoxy)benzyl|naphthalene compounds having estrogen inhibitory activity |
| 02/18/1999 | CA2298451A1 Secreted proteins and polynucleotides encoding them |
| 02/18/1999 | CA2297967A1 Purine inhibitor of protein kinases, g proteins and polymerases |
| 02/18/1999 | CA2274302A1 Lsr receptor, activity, cloning, and uses for diagnosing, preventing and/or treating obesity and related risks or complications |
| 02/18/1999 | CA2245041A1 Optical active 1,4-dihydropyridine compounds as bradykinin antagonists |
| 02/17/1999 | EP0897001A1 Polypeptide having a GTPase regulator activity, nucleic acids coding therefore and their use in diagnostics and therapy |
| 02/17/1999 | EP0896626A1 Monoclonal antibody to cea, conjugates comprising said antibody, and their therapeutic use in an adept system |
| 02/17/1999 | EP0896625A2 Recombinant ribonuclease proteins |
| 02/17/1999 | EP0896622A1 Chemokine alpha 2 |
| 02/17/1999 | EP0896586A1 ErbB3 ANTIBODIES |
| 02/17/1999 | EP0896584A2 BIOLOGICALLY ACTIVE PROTEIN (COLLAGEN FRAGMENT HF-COLL-18/514cf) FOR INHIBITING THE GROWTH OF TUMOURS AND CAPILLARY PROFILERATIONS |
| 02/17/1999 | EP0896582A1 Non-dendritic backbone peptide carrier |
| 02/17/1999 | EP0896577A1 Taxane derivatives having a pyridil substituted c13 side chain, their preparation and their use as anti-tumor agents |
| 02/17/1999 | EP0896544A1 Combination of a somatostatin analogue and a rapamycin |
| 02/17/1999 | EP0896543A1 Drug for the treatment of tumours |
| 02/17/1999 | EP0896537A1 Preparation containing a combination of 5-methylisoxazole-4-carboxylic acid-(4-trifluoromethyl)-anilide and n-(4-trifluoromethylphenyl)2-cyano-3-hydroxycrotonic acid amide |
| 02/17/1999 | EP0633774B1 Topical administration of toremifene and its metabolites |
| 02/17/1999 | CN1208413A Antagonists of gonadotropin releasing hormone |
| 02/17/1999 | CN1208412A Antagonists of gonadotropin releasing hormone |
| 02/17/1999 | CN1208409A Novel benzoyl guanidine derivatives process for their preparation and their use in the preparation of medicines |
| 02/17/1999 | CN1208034A Crystal form of N-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide |
| 02/17/1999 | CN1207946A Thioether conjugates |
| 02/17/1999 | CN1207940A Anticancer medicine and its preparation |
| 02/17/1999 | CN1207917A Application of theachrome in preparing potentiate and antidote for radiotherapy and chemotherapy medicine |
| 02/17/1999 | CN1207909A Oral liquid for curing cancer |
| 02/16/1999 | US5872242 Antisense oligonucleotide inhibition of ras |
| 02/16/1999 | US5872226 Fibroblast growth factor homologous factor-1 (FHF-1) |
| 02/16/1999 | US5872223 Immunoconjugates comprising tyrosine kinase inhibitors |
| 02/16/1999 | US5872152 Use of MMP inhibitors |
| 02/16/1999 | US5872146 Metalloproteinases involved in connective tissue breakdown, such as collagenase, stromelysin and gelatinase and tumor necrosis factor |
| 02/16/1999 | US5872142 1,3-dioxane or -dioxolane derivatives of 1h-1,2,4-triazole |
| 02/16/1999 | US5872140 Vitamin D analogues |
| 02/16/1999 | US5872129 Nitrobenzyl mustard quaternary salts and their use as hypoxia-selective cytotoxic agents |
| 02/16/1999 | US5872107 Anticarcinogenic agents capture therapy for tumors |
| 02/16/1999 | US5872106 Antimessenger oligonucleotide against urokinase receptor |
| 02/16/1999 | US5872007 CAPL-specific oligonucleotides and methods of inhibiting metastatic cancer |
| 02/16/1999 | US5871998 Gene expression in transformed eukaryotic host cell; genetic engineering |
| 02/16/1999 | US5871973 Cell division regulators |
| 02/16/1999 | US5871968 P21WAF1 derivatives and diagnostic methods |
| 02/16/1999 | US5871954 Acylation of peptide or protein by reacting with coenzyme a ester of an oxy- or thio-substituted fatty acid analog in presence of n-myristoyl transferase |
| 02/16/1999 | US5871779 Treatment of arthropathies with vanadate compounds or analogues thereof |
| 02/16/1999 | US5871727 Targeted adenovirus vectors |
| 02/16/1999 | CA2000913C Family of high affinity antibodies for cancer treatment |
| 02/15/1999 | CA2224096A1 The g-protein coupled receptor hfia041 |
| 02/14/1999 | CA2239264A1 Novel uses |
| 02/13/1999 | CA2244797A1 Droloxifene for prevention of breast cancer |
| 02/13/1999 | CA2240623A1 Novel rata |
| 02/12/1999 | CA2239835A1 Human sdr2 cdna clone |
| 02/11/1999 | WO1999006572A1 Synaptojanin isoform |
| 02/11/1999 | WO1999006544A1 Membrane-bound cytokine compositions and methods of modulating an immune response using same |
| 02/11/1999 | WO1999006540A2 Inhibitors of cell-cycle progression and uses related thereto |
| 02/11/1999 | WO1999006435A1 Dipeptide compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 02/11/1999 | WO1999006434A1 4-amino-phenylalanine type compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 02/11/1999 | WO1999006433A1 Compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 02/11/1999 | WO1999006431A1 Substituted phenylalanine type compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 02/11/1999 | WO1999006423A1 83 human secreted proteins |
| 02/11/1999 | WO1999006397A2 Pyrrolidine-3-carboxylic acid derivatives and their use as endothelin antagonists |
| 02/11/1999 | WO1999006393A1 Oligo-thiophenes useful as antimetastatic agents, a preparation thereof and pharmaceutical compositions containing them |
| 02/11/1999 | WO1999006391A1 Alpha-9 integrin antagonists and anti-inflammatory compositions therof |
| 02/11/1999 | WO1999006390A1 Carbamyloxy compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 02/11/1999 | WO1999006387A2 O-substituted hydroxycumaranone derivatives as antitumor and antimetastatic agents |
| 02/11/1999 | WO1999006372A1 Bis-acridinecarboxamides having antitumor activity |
| 02/11/1999 | WO1999006361A2 N-hydroxyformamide derivatives as inhibitors of matrix metalloproteinases |
| 02/11/1999 | WO1999006340A2 Sulfonylamino substituted hydroxamic acid derivatives as metalloprotease inhibitors |
| 02/11/1999 | WO1999006114A2 Use of taurolidine or taurultam for the manufacture of a medicament for the prevention of metastases |
| 02/11/1999 | WO1999006057A1 Soya extract, process for its preparation and pharmaceutical composition |
| 02/11/1999 | WO1999006055A1 Polynucleotide compositions |
| 02/11/1999 | WO1999006053A1 N6-substituted-adenosine-5'-uronamides as adenosine receptor modulators |
| 02/11/1999 | WO1999006041A1 SUBSTITUTED ALKANOHYDROXAMIC ACIDS AND METHOD OF REDUCING TNFα LEVELS |
| 02/11/1999 | WO1999006027A1 Pellet-type formulation intended for treating the intestinal tract |
| 02/11/1999 | WO1998050397A3 Chimeric oligonucleotides and the use thereof |
| 02/11/1999 | WO1998049311A3 Ricin-like toxin variants for treatment of cancer, viral or parasitic infections |
| 02/11/1999 | DE19728737C1 Verfahren zur Erkennung und Bestimmung von GnRH-Rezeptoren und die Verwendung von GnRH-Agonisten und GnRH-Antagonisten zur Behandlung eines Tumors ausgehend vom Hirn und/oder Nervensystem und/oder den Hirnhäuten A method for the detection and determination of GnRH receptors and the use of GnRH agonists and GnRH-antagonists for the treatment of a tumor originating in the brain and / or nervous system and / or the meninges |
| 02/11/1999 | CA2299045A1 Oligo-thiophenes useful as antimetastatic agents, a preparation thereof and pharmaceutical compositions containing them |
| 02/11/1999 | CA2298852A1 83 human secreted proteins |
| 02/11/1999 | CA2298617A1 Acyclic metalloprotease inhibitors |
| 02/11/1999 | CA2298573A1 Synaptojanin isoform |
| 02/11/1999 | CA2298115A1 Inhibitors of cell-cycle progression and uses related thereto |
| 02/11/1999 | CA2297894A1 Pyrrolidine-3-carboxylic acid derivatives and their use as endothelin antagonists |
| 02/11/1999 | CA2297747A1 Membrane-bound cytokine compositions and methods of modulating an immune response using same |
| 02/11/1999 | CA2296485A1 N6-substituted-adenosine-5'-uronamides as adenosine receptor modulators |
| 02/11/1999 | CA2296476A1 O-substituted hydroxycumaranone derivatives as antitumor and antimetastatic agents |
| 02/11/1999 | CA2295295A1 Substituted alkanohydroxamic acids and method of reducing tnf.alpha. levels |
| 02/11/1999 | CA2291475A1 Dipeptide compounds which inhibit leukocyte adhesion mediated by vla-4 |